Tuesday February 19, 2019

Protein Identified Enables New Drugs to Increase ‘Good Cholesterol’ Levels

Importantly, ORP2 could also be targeted to fight cancer. 

0
//
ORP2 could offer a new strategic line of research and possibly succeed where the use of statins in this area hasn't, Yang noted.

Researchers have identified a protein, known as ORP2, responsible for transporting cholesterol inside cells that opens the way for new drugs to increase the body’s ‘good cholesterol’ levels.

ORP2 can increase the amount of cholesterol in cells, a process called cholesterol efflux. We think this pathway will be very important for the development of a drug to increase this good cholesterol, said Rob Yang, Professor from the University of New South Wales in Australia.

Until now, drugs including statins have targeted bad cholesterol (LDL) by inhibiting its synthesis in the liver in an effort to mitigate the risk of heart disease and stroke.

However, while statins are effective at lowering LDL levels, they do little to increase the levels of good cholesterol (HDL) and there is no other drug in use that can significantly boost the human body’s HDL levels.

Congo
Researchers have identified a protein, known as ORP2, responsible for transporting cholesterol inside cells that opens the way for new drugs to increase the body’s ‘good cholesterol’ levels. . VOA

Up to 90 per cent of a cell’s cholesterol is found at the cell’s plasma membrane, said the study published in the journal Molecular Cell.

“Knowing the molecules that deliver cholesterol to the plasma membrane itself is a huge step forward. The transport of cholesterol to the plasma membrane is the key to the generation of HDL.

If such a drug could be developed, it would not replace statins, but would be used complementarily, with one drug used to reduce the bad cholesterol and the other to increase levels of the good, Yang suggested.

Also Read: Number of Students Opting for Science or Tech Are On Rise in India

Importantly, ORP2 could also be targeted to fight cancer.

Cancer, U.S.

Importantly, ORP2 could also be targeted to fight cancer.

The rampant and uncontrolled growth of cells that characterises cancer could be stopped in its tracks by reducing the amount of cholesterol produced.

ORP2 could offer a new strategic line of research and possibly succeed where the use of statins in this area hasn’t, Yang noted. (IANS)

Next Story

Know How Higher Intake of Sodium Can Treat Lightheadedness

Greater sodium intake is widely viewed as an intervention for preventing lightheadedness when moving from seated to standing positions.

0
sodium
"Health practitioners initiating sodium interventions for orthostatic symptoms now have some evidence that sodium might actually worsen symptoms," Juraschek said. Pixabay

Higher sodium intake should not be used as a treatment for lightheadedness, say researchers challenging current guidelines for sodium consumption.

Lightheadedness while standing, known as postural lightheadedness, results from gravitational drop in blood pressure and is common among adults.

Greater sodium intake is widely viewed as an intervention for preventing lightheadedness when moving from seated to standing positions.

However, contrary to this recommendation, researchers at Beth Israel Deaconess Medical Centre (BIDMC) found that higher sodium intake, actually increases dizziness.

“Our study has clinical and research implications,” said Stephen Juraschek, researcher from BIDMC in Boston.

salt
Greater sodium intake is widely viewed as an intervention for preventing lightheadedness when moving from seated to standing positions. Pixabay

“Our results serve to caution health practitioners against recommending increased sodium intake as a universal treatment for lightheadedness. Additionally, our results demonstrate the need for additional research to understand the role of sodium, and more broadly of diet, on lightheadedness,” Juraschek said.

For the study, reported in The Journal of Clinical Hypertension, the team used data from the completed DASH-Sodium trial, a randomised crossover study that looked at the effects of three different sodium levels (1500, 2300, and 3300 mg/d) on participants’ blood pressure for four weeks.

While the trial showed that lower sodium led to decrease in blood pressure, it also suggested that concerns about lower level of sodium causing dizziness may not be scientifically correct.

Also Read: ‘It Has Been A Very Long Process, But Ultimately A Very Successful Process’: South Korea Agrees to Pay More for U.S. Troops

The study also questioned recommendations to use sodium to treat lightheadedness, an intervention that could have negative effects on cardiovascular health.

“Health practitioners initiating sodium interventions for orthostatic symptoms now have some evidence that sodium might actually worsen symptoms,” Juraschek said.

“Clinicians should check on symptoms after initiation and even question the utility of this approach. More importantly, research is needed to understand the effects of sodium on physical function, particularly in older adults.” (IANS)